A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients

Annals of Oncology ◽

10.1093/annonc/mdn171 ◽

2008 ◽

Vol 19 (9) ◽

pp. 1547-1552 ◽

Author(s):

X. Pivot ◽

P. Koralewski ◽

J.L. Hidalgo ◽

A. Chan ◽

A. Gonçalves ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Multicenter Phase

Download Full-text

1876 A phase II study of metronomic oral chemotherapy for metastatic breast cancer patients: Safety and efficacy results of vinorelbine, cyclophosphamide plus capecitabine (VEX) combination

European Journal of Cancer ◽

10.1016/s0959-8049(16)30826-7 ◽

2015 ◽

Vol 51 ◽

pp. S291-S292 ◽

Author(s):

E. Montagna ◽

A. Lai ◽

A. Palazzo ◽

V. Bagnardi ◽

G. Cancello ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Oral Chemotherapy ◽

Breast Cancer Patients ◽

Safety And Efficacy

Download Full-text

5062 Fulvestrant in heavily pre-treated ER-positive post-menopausal metastatic breast cancer patients: final update of a phase II study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70954-1 ◽

2009 ◽

Vol 7 (2) ◽

pp. 279

Author(s):

R. Ratti ◽

Z. Coccorullo ◽

D. Guarneri ◽

G. Addamo ◽

G. Colloca ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Er Positive ◽

Post Menopausal

Download Full-text

P5-19-02: Comparison of the Incidence of Peripheral Neuropathy with Eribulin Mesylate Versus Ixabepilone in Metastatic Breast Cancer Patients: A Randomized Phase II Study.

10.1158/0008-5472.sabcs11-p5-19-02 ◽

2011 ◽

Author(s):

L Vahdat ◽

P Gopalakrishna ◽

AA Garcia ◽

C Vogel ◽

C Pellegrino ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Peripheral Neuropathy ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Eribulin Mesylate ◽

Randomized Phase Ii

Download Full-text

Phase II Study of Celecoxib and Trastuzumab in Metastatic Breast Cancer Patients Who Have Progressed after Prior Trastuzumab-Based Treatments

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-03-0463 ◽

2004 ◽

Vol 10 (12) ◽

pp. 4062-4067 ◽

Author(s):

Chau T. Dang ◽

Andrew J. Dannenberg ◽

Kotha Subbaramaiah ◽

Maura N. Dickler ◽

Mark M. Moasser ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients

Download Full-text

A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance

Breast Cancer ◽

10.1007/s12282-012-0344-3 ◽

2012 ◽

Vol 21 (1) ◽

pp. 20-27 ◽

Author(s):

Masakazu Toi ◽

Toshiaki Saeki ◽

Hiroji Iwata ◽

Kenichi Inoue ◽

Yutaka Tokuda ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Anthracycline Resistance ◽

Multicenter Phase

Download Full-text

Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study

Annals of Oncology ◽

10.1023/a:1008334227668 ◽

2001 ◽

Vol 12 (1) ◽

pp. 95-100 ◽

Author(s):

F. Nolè ◽

E. Munzone ◽

M. Mandalà ◽

C. Catania ◽

L. Orlando ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Continuous Infusion ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients

Download Full-text

A phase II study of gemcitabine plus capecitabine (GC) in heavily pre-treated metastatic breast cancer patients. The Swedish GC Breast Cancer Study Group

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(08)70736-5 ◽

2008 ◽

Vol 6 (7) ◽

pp. 175-176

Author(s):

A. Malmstrom ◽

J. Hansen ◽

L. Malmberg ◽

L. Carlsson ◽

J.H. Svensson ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Study Group ◽

Breast Cancer Patients ◽

Cancer Study Group ◽

Breast Cancer Study

Download Full-text

Clinical activity of cisplatin and prolonged oral administration of etoposide in previously treated, anthracycline-resistant, metastatic breast cancer patients: A phase II study

Medical and Pediatric Oncology ◽

10.1002/(sici)1096-911x(200001)34:1<10::aid-mpo2>3.0.co;2-a ◽

2000 ◽

Vol 34 (1) ◽

pp. 10-13 ◽

Author(s):

Getta Fried ◽

Moshe E. Stein ◽

Nissim Haim

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Oral Administration ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Clinical Activity ◽

Breast Cancer Patients ◽

Previously Treated

Download Full-text

Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1570-7 ◽

2011 ◽

Vol 68 (4) ◽

pp. 1009-1016 ◽

Author(s):

R. Murialdo ◽

F. Bertolotti ◽

G. Pastorino ◽

M. Mencoboni ◽

M. Bergaglio ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Weekly Docetaxel ◽

Multicenter Phase ◽

Download Full-text

Phase II Study of Oral 4-Demethoxydaunorubicin in Previously Treated (Except Anthracyclines) Metastatic Breast Cancer Patients

Oncology ◽

10.1159/000226450 ◽

1987 ◽

Vol 44 (2) ◽

pp. 82-86 ◽

Author(s):

K. Kolarić ◽

Z. Mechl ◽

V. Potrebica ◽

B. Šopkova

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Previously Treated

Download Full-text